Pharma out-licensing is a strategic approach where a pharmaceutical company licenses its assets, such as drugs or technologies, to external partners. The process and key steps of out-licensing are crucial for companies looking to expand their reach, enhance their product portfolios, and capitalize within the industry. This guide streamlines the out-licensing process, regardless of experience […]

In the dynamic landscape of the pharma industry, navigating the in-licensing process is a strategic imperative for companies seeking to strengthen their products. This complex journey involves identifying promising assets, negotiating agreements, and ultimately integrating external innovations. In-licensing refers to a formal collaboration where one company provides financial support to another to develop and launch […]